Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
myocilin | 0.595 | 0.500 | 7.6E-12 |
|
disease | 0.700 | None | 0.979 | 0 | 0 | 1995 | 2019 | ||||||||
|
latent transforming growth factor beta binding protein 2 | 0.572 | 0.692 | 7.4E-04 |
|
disease | 0.480 | None | 1.000 | 0 | 0 | 2009 | 2018 | ||||||||
|
solute carrier family 4 member 4 | 0.644 | 0.692 | 1.00 |
|
disease | 0.430 | None | 1.000 | 0 | 0 | 2004 | 2018 | ||||||||
|
paired like homeodomain 2 | 0.489 | 0.808 | 0.98 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2002 | 2018 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.360 | None | 0.875 | 0 | 0 | 2000 | 2018 | ||||||||
|
SH3 and PX domains 2B | 0.631 | 0.577 | 4.2E-03 |
|
disease | 0.310 | None | 1.000 | 0 | 0 | 2012 | 2012 | ||||||||
|
cytochrome P450 family 1 subfamily B member 1 | 0.457 | 0.769 | 2.2E-05 |
|
disease | 0.200 | None | 0.979 | 0 | 0 | 2000 | 2017 | ||||||||
|
lysyl oxidase like 1 | 0.590 | 0.615 | 0.89 |
|
disease | 0.200 | None | 0.923 | 0 | 0 | 2007 | 2019 | ||||||||
|
forkhead box C1 | 0.483 | 0.846 | 0.95 |
|
disease | 0.200 | None | 1.000 | 0 | 0 | 1998 | 2020 | ||||||||
|
gap junction protein alpha 1 | 0.393 | 0.885 | 0.16 |
|
disease | 0.180 | None | 1.000 | 0 | 0 | 2005 | 2019 | ||||||||
|
LIM homeobox transcription factor 1 beta | 0.565 | 0.731 | 0.75 |
|
disease | 0.170 | None | 1.000 | 0 | 0 | 1999 | 2018 | ||||||||
|
SET binding factor 2 | 0.619 | 0.577 | 6.4E-10 |
|
disease | 0.140 | None | 0.750 | 0 | 0 | 2003 | 2019 | ||||||||
|
NHS actin remodeling regulator | 0.466 | 0.846 | 1.00 |
|
disease | 0.140 | None | 1.000 | 0 | 0 | 2018 | 2020 | ||||||||
|
fibrillin 1 | 0.417 | 0.846 | 1.00 |
|
disease | 0.140 | None | 1.000 | 0 | 0 | 2000 | 2012 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.140 | None | 1.000 | 0 | 0 | 2005 | 2018 | ||||||||
|
elastin | 0.415 | 0.885 | 2.1E-14 |
|
disease | 0.130 | None | 1.000 | 0 | 0 | 1996 | 2010 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 10 | 0.641 | 0.500 | 0.84 |
|
disease | 0.120 | None | 1.000 | 0 | 0 | 2013 | 2014 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
disease | 0.120 | None | 1.000 | 0 | 0 | 2008 | 2019 | ||||||||
|
paired box 6 | 0.450 | 0.769 | 1.00 |
|
disease | 0.120 | None | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
collagen type I alpha 1 chain | 0.430 | 0.808 | 1.00 |
|
disease | 0.120 | None | 1.000 | 0 | 0 | 2016 | 2018 | ||||||||
|
peroxisomal biogenesis factor 19 | 0.585 | 0.731 | 3.2E-04 |
|
disease | 0.120 | None | 1.000 | 0 | 0 | 2017 | 2017 | ||||||||
|
TEK receptor tyrosine kinase | 0.462 | 0.692 | 1.00 |
|
disease | 0.120 | None | 1.000 | 0 | 0 | 2017 | 2018 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.120 | None | 1.000 | 0 | 0 | 1999 | 2005 | ||||||||
|
collagen type XI alpha 1 chain | 0.495 | 0.846 | 1.00 |
|
disease | 0.120 | None | 1.000 | 0 | 0 | 2012 | 2014 | ||||||||
|
forkhead box E3 | 0.568 | 0.654 | 0.18 |
|
disease | 0.110 | None | 1.000 | 0 | 0 | 2015 | 2015 |